Case report of apatinib mesylate treatment in rare advanced tracheal adenoid cystic carcinoma.

Related Articles

Case report of apatinib mesylate treatment in rare advanced tracheal adenoid cystic carcinoma.

Thorac Cancer. 2017 Nov;8(6):729-733

Authors: Wang H

Abstract
A 57-year-old man was admitted to our department 10 years ago, diagnosed with tracheal adenoid cystic carcinoma. After discontinuing chemotherapy and radiotherapy, the disease recurred in December 2016. Apatinib mesylate (500 mg/day) was administered and computed tomography revealed that his symptoms were significantly relieved. Treatment with apatinib mesylate represents a novel method of treatment for tracheal adenoid cystic carcinoma.

PMID: 28892250 [PubMed - indexed for MEDLINE]

http://ift.tt/2psZCxE